Not Signed In - Medivation's Dimebon(TM) Phase 2 Trial Results To Be Presented At 8th International Conference On Alzheimer's And Parkinson's Diseases
Wed, 31 Jan 2007 08:00 AM EST
... Medivation, Inc. (Amex: MDV) today announced that results of its Phase 2 efficacy study of Dimebon(TM) in Alzheimer's disease will be presented at the 8th International Conference on Alzheimer's and Parkinson's Diseases: Progress and New Perspectives in Salzburg, Austria. This marks the first scientific meeting at which data from the trial will be presented. [click link for full article] ...
Related Topics
- Clinical Trials
- Alzheimer's Disease
- Parkinson's Disease
- International Health
- International Classification of Diseases
- Sexually Transmitted Diseases
- Alzheimer's Caregivers
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Parkinson's Disease Medications
- Eye Diseases
- Child Abuse And Neglect
- Travel Health
- Psychopharmacology
- Peritoneal Dialysis
- Parkinson disease
- Liver Diseases And Disorders
- Dysphagia
- Congenital Heart Disease
- Alzheimer disease
email this page
print this page
bookmark this page
feedback on this page
